Complete Pharmacy And Medical Solutions, LLC.
FDA Regulatory Profile
Complete Pharmacy And Medical Solutions, LLC. has 6 FDA recalls (2 Class I), 2 inspections, 0 510(k) clearances and 1 compliance action on record.
- Latest recall
- D-0237-2021 · Class II · Nov 20, 2020
- Latest inspection
- Jan 23, 2019 · OAI
Reviewing Complete Pharmacy And Medical Solutions, LLC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Check this supplier
Or check Complete Pharmacy And Medical Solutions, LLC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Get a free API key
Summary
Record counts and when each FDA source was last refreshed
| Records | Count | Last refreshed | Source as of | Status |
|---|
| Recalls | 6 (2 Class I) | Nov 4, 2026 (checked Nov 8, 2026, unchanged) | File dated Nov 3, 2026 | Current |
|---|
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
|---|
| Inspections | 2 | Nov 10, 2026 | Newest record Nov 5, 2026 | Current |
|---|
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
|---|
Recent Recalls
| Number | Class | Product | Date |
|---|
| D-0237-2021 | Class II | HUMAN CHORIONIC GONADOTROPIN 1,250 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in… | Nov 20, 2020 |
| D-0234-2021 | Class II | HUMAN CHORIONIC GONADOTROPIN 11,000 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in… | Nov 20, 2020 |
| D-0235-2021 | Class II | HUMAN CHORIONIC GONADOTROPIN 6,000 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in… | Nov 20, 2020 |
| D-0236-2021 | Class II | HUMAN CHORIONIC GONADOTROPIN 5,000 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in… | Nov 20, 2020 |
| D-0918-2017 | Class I | Human Chorionic Gonadotropin, 15,000 IU per vial, lyophilized for injection, Rx only, Complete… | Apr 2, 2016 |
| D-0917-2017 | Class I | Human Chorionic Gonadotropin, 125 IU HCG, in 0.5 ml syringe, subcutaneous administration, Rx only… | Dec 29, 2015 |
Recent FDA Inspections
NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.
FDA-Inspected Facilities
| Facility | Location | Inspections | Latest |
|---|
| FEI 3010922197 | Miami Lakes, FL | 2 | Jan 23, 2019 |